Share on :

Asset Summary

Weekly Performance Report for ABBV ETF: Week 47, 2024

Summary: The Weekly started with ABBV ETF opening at $166.28 and closing at $176.95. The ETF showed resilience throughout the Weekly, with the highest price observed at $178.86 and the lowest at $163.81. The underlying asset had a trading range of $15.05 Overall, it was a positive trading Weekly for ABBV ETF, reflecting investor optimism and market activity.

Change in Closing Price: There was a net increase of $10.67 or 6.42% in the closing price from the opening to the closing price over the Weekly.

Volume Analysis: Trading volume for ABBV ETF was 30,559,773 units during Week 47, indicating active market participation and investor interest.

Opening Price: The Weekly started at $166.28.

Highest Price: The highest price observed during the Weekly was $178.86.

Lowest Price: The lowest price observed during the Weekly was $163.81.

Closing Price: The Weekly ended at $176.95.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Unlock Your ABBV Trading Now

Discover unparalleled trading insights with RankMyTrade Platform. Our automated system offers advanced analysis and technical indicators for ABBV, aimed at optimizing your trading decisions. Enhance your market performance today and get ahead in the market now!

Unlock Full Potential Now

Frequently Asked Questions

Historically, ABBV has demonstrated strong performance, particularly driven by its flagship products in immunology and oncology.

Yes, ABBV can be held in retirement accounts such as IRAs or 401(k)s, making it a suitable choice for long-term investment strategies.

ABBV’s performance can be compared to other biopharmaceutical companies, focusing on product pipeline success, market share, and revenue growth.

ABBV does not undergo traditional rebalancing like an ETF, but it regularly assesses its product pipeline and strategic initiatives to optimize performance.

ABBV offers a range of pharmaceuticals, including treatments for immunological conditions, oncology therapies, and neuroscience-related medications.

Key metrics include revenue growth, earnings per share (EPS), net income, and return on equity (ROE), which indicate the company’s financial health.

ABBV typically distributes dividends on a quarterly basis, providing a steady income stream for investors.

Yes, risks include competition in the biopharmaceutical space, regulatory challenges, and the potential for patent expirations on key products.

Investors can purchase shares of ABBV through a brokerage account, as it is publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol "ABBV."

Dividends paid by ABBV can be reinvested to purchase additional shares or received in cash, depending on the investor’s preference.

Unlock Your ABBV Trading Now

Take control of your trading with Rank My Trade. Our platform offers unparalleled analysis and technical support for ABBV, designed to enhance your market performance. Enhance your market performance today today and experience the difference with our expert tools!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs